Preoperative treatment combined with intraarterial chemotherapy and radiotherapy for head and neck cancers. Comparison of carboplatin vs. cisplatin in adverse effects.
3) Calvert, A. H., Harland, S. J., et al.: Early clinical studies with cis-diammine-1, 1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol 9: 140-147 1982.
4) Joss, R. A., Kaplan, S., et al: A phase I trial of cis-diammine-1, 1-cyclobutane dicarboxylate platinum II (Carboplatin, CBDCA, JM-8) with a single dose every five week schedule. Investigational New Drugs 2: 297-304 1984.
5) Foster, B. J., Clagett-Carr, K., et al.: Results of NCI-sponsored phase I trials with carboplatin. Cancer Treat Rev 12 (Suppl. A): 43-49 1985.